0001209191-18-014675.txt : 20180228 0001209191-18-014675.hdr.sgml : 20180228 20180228184031 ACCESSION NUMBER: 0001209191-18-014675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAN OORT DOUGLAS M CENTRAL INDEX KEY: 0001518733 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 18653639 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-26 0 0001077183 NEOGENOMICS INC NEO 0001518733 VAN OORT DOUGLAS M 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 Chairman and CEO Common Stock 187500 I Conundrum Capital Partners Common Stock 1832985 D Stock Option (Right to Buy) 7.15 2017-04-20 2021-04-20 Common Stock 472527 472527 D Stock Option (Right to Buy) 7.52 2018-04-28 2022-04-28 Common Stock 500000 500000 D Restricted Stock 0.00 2018-05-25 Common Stock 197042 197042 D Stock Option (Right to Buy) 8.03 2018-02-26 4 A 0 636000 8.03 A 2019-02-26 2023-02-26 Common Stock 636000 636000 D Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of Conundrum Capital Partners, LLC Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. Van Oort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014. On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date. On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Restricted stock will vest as follows; 65,680 units will vest on May 25, 2018 and 65,681 units will vest on May 25, 2019 and 2020. These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date. On February 26, 2018, Mr. VanOort was granted 636,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. /s/ Douglas M. VanOort 2018-02-28